Callan JMB Advances U.S. Pharmaceutical Manufacturing Efforts
News related to:Callan JMB Inc · 3 min read
SPRING BRANCH, Texas, Oct. 08, 2026 /CourierPR/ -- Callan JMB Inc., a diversified preparedness, logistics, and critical-infrastructure company, has announced significant progress toward establishing domestic pharmaceutical manufacturing at the Atlas Complex in Marion, Alabama. The company has signed an initial purchase order and is expected to make a $500,000 down payment toward approximately $28 million in pharmaceutical manufacturing equipment planned for installation at the Atlas Complex. The collaboration also provides for Callan JMB to serve as a North American distributor and assembly provider for TRUKING equipment, extending the Company’s participation beyond the initial Atlas deployment to equipment distribution and assembly for additional planned pharmaceutical manufacturing sites and other commercial customers.
The initiative builds on Callan JMB’s longstanding emergency-preparedness and response work by connecting planned domestic pharmaceutical production with the logistics, regulatory compliance, specialty packaging, warehousing, monitoring, and distribution capabilities used to protect and deliver critical supplies. Bringing these functions together at the Atlas Complex in Marion, Alabama is intended to support continuity of supply during routine operations and periods of heightened demand or disruption. Equipment distribution and assembly would also broaden the Company’s commercial participation in the infrastructure supporting pharmaceutical manufacturing.
The initial equipment deployment is being coordinated with development of the planned 90,000-square-foot Marion 9 manufacturing facility at the Atlas Complex. The facility is intended to support U.S. production of pharmaceutical products affected by critical supply shortages, with equipment fabrication and facility construction expected to proceed in parallel. TRUKING is an international supplier of pharmaceutical equipment and integrated manufacturing solutions. The collaboration brings its specialized equipment capabilities into a U.S. manufacturing project, with equipment specifications being developed at the Atlas Complex facility. TRUKING will fabricate the equipment at its facilities in China, then ship it to Alabama for Callan JMB to assemble and install. The planned pharmaceutical production will take place at the Atlas Complex, supporting the initiative’s objective of expanding domestic manufacturing capacity.
Callan JMB plans to establish a dedicated assembly team to support the Atlas Complex installation and subsequent equipment deployments. Company teams are expected to participate in pre-shipment testing and qualification activities and support installation, qualification, and validation at Atlas in preparation for manufacturing operations. Management currently anticipates approximately nine months for equipment fabrication and six to nine months for facility construction. Initial production is targeted before the end of 2027, subject to completion of construction, equipment delivery and installation, commissioning, validation, and applicable regulatory requirements.
The planned production model combines active pharmaceutical ingredients expected to be supplied by Walker’s Pharmaceuticals with fill-finish capabilities at the Atlas Complex. Callan JMB’s supporting services are intended to connect those manufacturing activities with the storage, packaging, handling, and distribution required to deliver finished products to healthcare and commercial customers.
Callan JMB Inc. (NASDAQ: CJMB) is a diversified logistics, preparedness, and critical-infrastructure company supporting healthcare organizations, government agencies, and commercial partners. The Company provides fulfillment, warehousing, cold-chain logistics, monitoring, regulatory compliance, specialty packaging, and emergency-preparedness and response services designed to protect critical products, strengthen supply chains, and support continuity of operations. Through its portfolio of businesses, strategic partnerships, and acquisitions, Callan JMB is building a broader platform spanning healthcare and pharmaceutical logistics, domestic manufacturing, transformer and critical electrical-equipment manufacturing, critical-infrastructure services, and energy development. For more information, visit callanjmb.com.
The Securities Act of 1933 on Form S-1, including
Callan JMB Inc. (NASDAQ: CJMB) is a diversified logistics, preparedness, and critical-infrastructure company supporting healthcare organizations, government agencies, and commercial partners. The Company provides fulfillment, warehousing, cold-chain logistics, monitoring, regulatory compliance, specialty packaging, and emergency-preparedness and response services designed to protect critical products, strengthen supply chains, and support continuity of operations. Through its portfolio of businesses, strategic partnerships, and acquisitions, Callan JMB is building a broader platform spanning healthcare and pharmaceutical logistics, domestic manufacturing, transformer and critical electrical-equipment manufacturing, critical-infrastructure services, and energy development. For more information, visit callanjmb.com.